Valuation: Cegedim

Market Cap 145M 167M 137M 124M 233M 16.03B 234M 1.63B 628M 8.13B 628M 614M 25.92B P/E 2026 *
6.91x
P/E 2027 * 5.27x
Enterprise Value 307M 354M 290M 263M 493M 33.98B 497M 3.46B 1.33B 17.23B 1.33B 1.3B 54.95B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.38%
1 week+2.92%
Current month+2.12%
3 months-6.54%
6 months+6.01%
Current year-21.92%
1 week 10.2
Extreme 10.2
10.6
1 month 10.1
Extreme 10.1
10.6
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
19.78
5 years 8.5
Extreme 8.5
29.25
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Date Insider Type Main position Quantity % Market Cap. Importance
4/30/26 Buy 751 0.0053%
4/28/26 Buy 74,537 0.5287%
4/16/26 Buy 500 0.0035%
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%+2.92%+3.73%-45.74% 167M
-1.16%-12.00%-52.67%+25.55% 438B
+0.44%+2.96%-12.84%+47.05% 248B
+1.91%+8.59%-23.08%+25.73% 147B
-3.20%-3.65%-59.87%+286.00% 52.62B
-2.67%+1.62%-32.59%+0.70% 45.07B
-1.47%+5.53%-36.67%+10.49% 21.63B
-1.70%-1.70%-18.64%+62.65% 19.24B
+0.33%+0.48%-27.10%+15.04% 13.7B
+4.86%+12.78%-10.02%+67.01% 13.04B
Average -0.12%-0.62%-26.97%+49.45% 99.85B
Weighted average by Cap. -0.23%-3.48%-35.97%+44.29%

Financials

2026 *2027 *
Net sales 660M 761M 624M 565M 1.06B 73.04B 1.07B 7.44B 2.86B 37.04B 2.86B 2.8B 118B 684M 790M 647M 586M 1.1B 75.75B 1.11B 7.72B 2.97B 38.41B 2.97B 2.9B 122B
Net income 21.3M 24.59M 20.14M 18.23M 34.22M 2.36B 34.48M 240M 92.47M 1.2B 92.37M 90.32M 3.81B 28M 32.33M 26.48M 23.97M 44.99M 3.1B 45.33M 316M 122M 1.57B 121M 119M 5.01B
Net Debt 162M 187M 153M 139M 261M 17.96B 262M 1.83B 704M 9.11B 703M 688M 29.04B 134M 154M 126M 115M 215M 14.81B 217M 1.51B 581M 7.51B 580M 567M 23.95B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
26-09-15 10.58 +0.38% 6,020
26-09-14 €10.54 +2.13% 6,237
26-09-11 €10.32 0.00% 2,782
26-09-10 €10.32 0.00% 22,725
26-09-09 €10.32 +0.39% 14,785
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.54EUR
Average target price
15.50EUR
Spread / Average Target
+47.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCGM Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!